Status:
COMPLETED
Manchester Antenatal Vascular Service
Lead Sponsor:
Manchester University NHS Foundation Trust
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Conditions:
Vascular Disease
Eligibility:
FEMALE
Brief Summary
25-30% of women with preexisting vascular disease (chronic hypertension/diabetes/obesity) will develop pre-eclampsia and or growth restriction. In addition, the frequency of stillbirths in this group ...
Eligibility Criteria
Inclusion
- Women with preexisting vascular disease:
- chronic hypertension BP ≥140/90 at ≤14 weeks
- chronic hypertension requiring antihypertensive treatment ≤ 14 weeks
- pre gestational diabetes with evidence of vascular complications (hypertension, nephropathy)
- history of ischemic heart disease
- previous early onset pre-eclampsia (delivery \< 32 weeks)
- Obesity (BMI ≥ 40) with any history of hypertension or booking BP≥130/80
Exclusion
- Women who do not meet the inclusion criteria
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT02244385
Start Date
July 1 2011
End Date
December 1 2017
Last Update
December 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternal & Fetal Health Research Centre, 5th Floor St Mary's Hospital
Manchester, United Kingdom, M13 9WL